Professional Overview
Kemi N is a seasoned Market Access HEOR Professional currently based in London, England, United Kingdom. In her current role, she leverages her expertise in market access, health economics, and outcomes research to drive business growth and inform strategic decisions. Her key expertise areas include market access strategy, health economics, and outcomes research, with a focus on the pharmaceutical industry.
Experience Summary
Current Role
As a Market Access HEOR Professional at AbbVie, Kemi has been responsible for developing and implementing market access strategies, conducting health economic analyses, and providing insights to inform business decisions. Her key responsibilities include market research, data analysis, and stakeholder engagement. Although specific achievements are not available, her role has likely involved collaborating with cross-functional teams to drive business outcomes and improve patient access to innovative treatments.
Career Progression
Kemi's career trajectory spans several notable roles in the pharmaceutical industry. Prior to her current position, she worked as a Market Access HEOR Professional at Novartis, where she applied her expertise in market access and health economics to support business objectives. Earlier in her career, she held roles at UnitedHealth Group, NHS, and Sanofi Pasteur MSD, gaining valuable experience in commissioning, contracting, and market access management. These roles have contributed to her growth as a professional and equipped her with a deep understanding of the industry.
Areas of Expertise
Kemi's areas of expertise include market access strategy, health economics, and outcomes research. She possesses technical competencies in data analysis, market research, and stakeholder engagement. Her leadership and management capabilities have been demonstrated through her ability to collaborate with cross-functional teams and drive business outcomes.
Professional Impact
Although specific projects or initiatives are not available, Kemi's work in market access and health economics has likely contributed to improved patient outcomes and increased access to innovative treatments. Her experience in the pharmaceutical industry has equipped her with a unique understanding of the complexities of market access and the importance of health economic analysis in informing business decisions.
Conclusion
Kemi N is a dedicated and experienced Market Access HEOR Professional with a strong track record of driving business growth and improving patient access to innovative treatments. Her current focus on market access strategy, health economics, and outcomes research positions her as a valuable asset to her organization. With her unique blend of technical expertise, industry knowledge, and leadership capabilities, Kemi is well-equipped to continue making meaningful contributions to the pharmaceutical industry.
